MX9205438A - Combinaciones de substancias activas que contienen polipeptidos con actividad del factor de crecimiento de los fibroblastos y polielectrolitos. - Google Patents

Combinaciones de substancias activas que contienen polipeptidos con actividad del factor de crecimiento de los fibroblastos y polielectrolitos.

Info

Publication number
MX9205438A
MX9205438A MX9205438A MX9205438A MX9205438A MX 9205438 A MX9205438 A MX 9205438A MX 9205438 A MX9205438 A MX 9205438A MX 9205438 A MX9205438 A MX 9205438A MX 9205438 A MX9205438 A MX 9205438A
Authority
MX
Mexico
Prior art keywords
fibroblastes
polyelectrolytes
activity
combinations
growth factor
Prior art date
Application number
MX9205438A
Other languages
English (en)
Inventor
Berhold Nies
Original Assignee
Merck Patent Gmbh
Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh, Haftung filed Critical Merck Patent Gmbh
Publication of MX9205438A publication Critical patent/MX9205438A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MX9205438A 1991-09-26 1992-09-24 Combinaciones de substancias activas que contienen polipeptidos con actividad del factor de crecimiento de los fibroblastos y polielectrolitos. MX9205438A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4132005A DE4132005A1 (de) 1991-09-26 1991-09-26 Kombination enthaltend wachstumsfaktoren und polyelektrolyte

Publications (1)

Publication Number Publication Date
MX9205438A true MX9205438A (es) 1993-03-01

Family

ID=6441511

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205438A MX9205438A (es) 1991-09-26 1992-09-24 Combinaciones de substancias activas que contienen polipeptidos con actividad del factor de crecimiento de los fibroblastos y polielectrolitos.

Country Status (16)

Country Link
US (2) US5885960A (es)
EP (1) EP0534310A1 (es)
JP (1) JPH05213766A (es)
KR (1) KR930005633A (es)
AU (1) AU2525092A (es)
CA (1) CA2079042A1 (es)
CZ (1) CZ281452B6 (es)
DE (1) DE4132005A1 (es)
HU (1) HUT64479A (es)
MX (1) MX9205438A (es)
NO (1) NO923746L (es)
PL (1) PL296034A2 (es)
RU (1) RU2080872C1 (es)
SK (1) SK265692A3 (es)
TW (1) TW273512B (es)
ZA (1) ZA927398B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221840B1 (en) * 1991-02-14 2001-04-24 The General Hospital Corporation Intestinal trefoil proteins
DE4132005A1 (de) * 1991-09-26 1993-04-01 Merck Patent Gmbh Kombination enthaltend wachstumsfaktoren und polyelektrolyte
US6525018B1 (en) 1999-05-17 2003-02-25 The General Hospital Corp. Treating eye disorders using intestinal trefoil proteins
US7023129B1 (en) 1999-10-22 2006-04-04 Matsushita Electric Industrial Co., Ltd. Cathode-ray tube and image display comprising the same
DE10022656B4 (de) * 2000-04-28 2006-07-06 Infineon Technologies Ag Verfahren zum Entfernen von Strukturen
US7538082B2 (en) 2001-04-24 2009-05-26 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
TW527722B (en) * 2002-03-20 2003-04-11 Macronix Int Co Ltd Non-volatile memory device and fabrication method thereof
KR20050090430A (ko) * 2002-12-31 2005-09-13 알투스 파마슈티컬스 인코포레이티드 인간 성장 호르몬 결정 및 이것의 제조 방법
ZA200505306B (en) * 2002-12-31 2006-09-27 Altus Pharmaceuticals Inc Complexes of protein crystals and ionic polymers
US20090023629A1 (en) * 2005-12-23 2009-01-22 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
US9174839B2 (en) * 2008-01-30 2015-11-03 Imbed Biosciences, Inc. Methods and compositions for wound healing
EP3574909A1 (en) 2008-01-30 2019-12-04 Imbed Biosciences, Inc. Methods and compositions for wound healing
BRPI0801422B8 (pt) 2008-03-26 2021-05-25 Fund Sao Francisco Xavier composição e método para inibição da severidade das aderências pós-cirúrgicas
CA2796459C (en) 2010-04-16 2016-05-24 Salk Institute For Biological Studies Methods for treating metabolic disorders using fgf-1
WO2015061331A1 (en) 2013-10-21 2015-04-30 Salk Institute For Biological Studies Chimeric fibroblast growth factor (fgf) 2/fgf1 peptides and methods of use
MX2016005101A (es) 2013-10-21 2017-01-09 Salk Inst For Biological Studi Factor de crecimiento de fibroblastos (fgf) 1 mutado y procedimientos de uso.
WO2017075260A1 (en) 2015-10-30 2017-05-04 Salk Institute For Biological Studies Treatment of steroid-induced hyperglycemia with fibroblast growth factor (fgf) 1 analogs
EP4289910A3 (en) 2016-07-29 2024-03-13 Imbed Biosciences, Inc. Methods and compositions for wound healing
US11542309B2 (en) 2019-07-31 2023-01-03 Salk Institute For Biological Studies Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose
RU2734819C1 (ru) * 2019-12-12 2020-10-23 Общество с ограниченной ответственностью "ИНТЭКОС" (ООО "ИНТЭКОС") Композиция для лечения ран и ожогов (варианты)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783412A (en) * 1983-07-05 1988-11-08 Chiron Corporation Hybrid DNA synthesis of epidermal growth factor
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
JPS61253065A (ja) * 1985-05-02 1986-11-10 片倉チツカリン株式会社 キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
WO1987001728A1 (en) * 1985-09-12 1987-03-26 Biotechnology Research Partners, Ltd. Recombinant fibroblast growth factors
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
DE4132005A1 (de) * 1991-09-26 1993-04-01 Merck Patent Gmbh Kombination enthaltend wachstumsfaktoren und polyelektrolyte

Also Published As

Publication number Publication date
TW273512B (es) 1996-04-01
CZ265692A3 (en) 1993-04-14
HU9203079D0 (en) 1992-12-28
NO923746D0 (no) 1992-09-25
ZA927398B (en) 1993-04-02
EP0534310A1 (de) 1993-03-31
PL296034A2 (en) 1993-07-12
NO923746L (no) 1993-03-29
SK265692A3 (en) 1994-06-08
AU2525092A (en) 1993-04-01
KR930005633A (ko) 1993-04-20
DE4132005A1 (de) 1993-04-01
HUT64479A (en) 1994-01-28
US6147053A (en) 2000-11-14
JPH05213766A (ja) 1993-08-24
CA2079042A1 (en) 1993-03-27
RU2080872C1 (ru) 1997-06-10
US5885960A (en) 1999-03-23
CZ281452B6 (cs) 1996-10-16

Similar Documents

Publication Publication Date Title
MX9205438A (es) Combinaciones de substancias activas que contienen polipeptidos con actividad del factor de crecimiento de los fibroblastos y polielectrolitos.
DE3673114D1 (de) Zerstaeuber und dessen dochtanordnung.
ITTO920761A0 (it) Articolo assorbente con distribuzione controllata del liquido.
DE69323524D1 (de) Nadelloser Einweg-Injektor
DE68923528D1 (de) Pyrazolamide und diese enthaltende Insektizide und Mitizide.
DE3579655D1 (de) Arzneimittel zur externen anwendung enthaltend aktives vitamin-d3.
DK137488D0 (da) Praeparater med kontrolleret frigivelse af aktive stoffer
DE68909822D1 (de) Flüssigkeitsbehälter.
DE3884791D1 (de) Begasungs-Brutschrank.
DE3778757D1 (de) Lagerungs- und verteilungsmittel.
DE68922886D1 (de) Flüssigkeitsbehälter.
DE68924698D1 (de) Flüssigkeitsbehälter.
DE3789294D1 (de) Triazin-Derivate und diese enthaltende Herbizide.
DE69328330D1 (de) Analoger Multiplexer mit Standby-Betrieb
TR24676A (tr) Icindeki bulunan herhangi bir siviyi tamamen bosaltabilme oezelligine haiz enjeks
ATE36506T1 (de) Fadenspeicher- und liefervorrichtung.
NO881109D0 (no) Middel til innsekt- og middbeskyttelse.
ATE108397T1 (de) Auspressbarer flüssigkeitsbehälter.
DE68916136D1 (de) Laservorrichtungen und Lasersystem mit diesen Vorrichtungen.
NO905251D0 (no) Fremgangsmaate for serie - fremstilling av ammunisjonslegemer samt ammunisjonslegemer fremstilt i henhold til fremgangsmaaten.
DE68915798D1 (de) Filmentwicklungseinsatz und Tank.
NO894399D0 (no) Optisk aktive benzoksasiner og benzotiaziner.
PT99061A (pt) Combinacoes de substancias activas do tipo piretroide, contendo benflutrin e pralletrin
DE69112153D1 (de) Pegelumsetzer mit Einzelsteuerung und niedriger dynamischer Impedanz.
DE3764934D1 (de) Lagersystem mit hochregallager und foerdereinrichtungen.